跳至主要内容
临床试验/NCT02949310
NCT02949310Unknown不适用

Effectiveness of Nefopam in Breast Cancer Surgery

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2016年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
88
试验地点
1
主要终点
Change of cumulative analgesia volume infused via intravenous patient-controlled analgesia device

研究概览

简要总结

Breast cancer surgery is known to cause severe acute postoperative pain, which can persist for a long time. The investigators administered nefopam preventively to patients undergoing total mastectomy or modified radical mastectomy with axillary lymph node dissection or sentinel lymph node biopsy, and evaluated its efficacy on acute and chronic postoperative pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Total mastectomy
  • Modified radical mastectomy
  • Nipple-sparing mastectomy
  • American Society of Anesthesiologists physical status I or II
  • Postoperative use of intravenous patient-controlled analgesia

排除标准

  • Chronic analgesia medication
  • Pregnancy
  • Lactating women
  • Previous operation history due to breast cancer
  • Cooperation with other surgery
  • Contraindication of nefopam

研究组 & 干预措施

Control

Placebo Comparator

Placebo use instead of nefopam

干预措施: Normal Saline (Drug)

Nefopam

Experimental

Intraoperative use of nefopam 40 mg

干预措施: Nefopam (Drug)

结局指标

主要结局

Change of cumulative analgesia volume infused via intravenous patient-controlled analgesia device

时间窗: At postoperative 4 hour, 24 hour, 48 hour, 72 hour, 10 day, and 3 month

次要结局

  • Change of numerical rating scale for postoperative pain(At postoperative 4 hour, 24 hour, 48 hour, 72 hour, 10 day, and 3 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyo-Seok Na

Clinical professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验